Are we looking at the right part of the prescription drug pricing problem?
There's a lot of current debate about prescription drug prices. Most of it seems to focused on PBMs, rebates and transparency. Those are some issues but drug manufacturers set the initial prices for the medicines.
I'm interested on hearing from people who work in healthcare or who have dealt this with. Should the policymakers put the most attention on manufacturer prices, PBM practices or insurance coverage, if their goal is to lower what patients pay?